544
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Comparison of GFR calculation methods: MDRD and CKD-EPI vs. 99mTc-DTPA tracer clearance rates

, , &
Pages 334-338 | Received 10 Dec 2012, Accepted 23 Feb 2013, Published online: 16 Apr 2013
 

Abstract

Introduction. Glomerular filtration rate (GFR) is considered the best index of kidney function. The Modification of Diet in Renal Disease (MDRD)-Study equation has gained worldwide acceptance for estimating GFR from serum creatinine. Recently the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) group developed a new equation that claims to be more accurate and could replace MDRD for routine clinical use. Nuclear medicine methods are accepted as more accurate, and have become regular practice provided they are easily available. The aim of this study was to evaluate how indirect GFR calculations correlated with the nuclear medicine method. Materials and methods. The authors compared 99mTc-DTPA clearance using the Gates method and a two-blood sample method with MDRD and CKD-EPI, in a population of renal donor candidates and oncological patients treated with nephrotoxic chemotherapy. Results. Our results showed that even though both equations provided a good correlation (p < 0.001) with GFR evaluated by the nuclear medicine method, they underestimated the GFR value in comparison to nuclear medicine methods. Our study also found that CKD-EPI was superior to MDRD. Conclusion. Using purely creatinine-based GFR estimates can lead to complications in clinical practice, especially when correct GFR values are mandatory, like when calculating adequate chemotherapy dosage, and should be used with caution. When the more accurate nuclear medicine methods are unavailable due to cost or accessibility issues, our study showed that the new CKD-EPI appears to reflect GFR results more accurately than MDRD, and thus should be the method of choice for estimating GFR.

Declaration of interest: The authors report no conflict of interest. The authors alone are responsible for the content and writing of the article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.